| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | VR8ERK4H7B |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | ICOS ligand inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sjogren's Syndrome | 2 | D012859 | ClinicalTrials |
| Psoriasis | 1 | D011565 | ClinicalTrials |
| Lupus Erythematosus, Cutaneous | 1 | D008178 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 1 | D008180 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109249 |
| FDA SRS | VR8ERK4H7B |
CONTENTS